Global Lab-on-a-chip and Microarrays (Biochip) Market size study by Type (Lab-on-a-chip and Microarrays), Product (Instruments, Reagents and Consumables, and Software and Services), Application (Clinical Diagnostics, Drug Discovery, Genomics and Proteomics, and Other Applications), End-User (Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostics Centers and Academic and Research Institutes), Regional Forecasts 2021-2027
- Category: Retail & Consumer
- Published Date: Oct 2021
- Publisher: Bizwit Research
- Pages: 200
Global Lab-on-a-Chip and Microarrays (Biochip) Market is valued approximately at USD 13.36 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 13.96% over the forecast period 2021-2027. A lab-on-chip is a micro device that combines several laboratory analysis procedures onto a single chip. Using lab-on-chip technology, many laboratory analysis techniques such as biochemical detection, DNA sequencing, PCR, and others may be smoothly integrated. Parallelization, high assay sensitivity, ergonomy, waste minimization, and other benefits are all connected with this technique. The chip utilized in this technique can be as tiny as a few square centimeters and can handle very small fluid quantities, as low as picoliters. In the near future, the lab-on-chip market is expected to grow significantly. The rising demand for point-of-care testing, increasing incidences of chronic illnesses, and expanding use of proteomics and genomics in cancer research are the main drivers driving the overall market. For instance, according to the World Health Organization (WHO), chronic disease prevalence is expected to rise by 57 percent by 2020, with developing markets bearing 60 percent of the burden. Chronic diseases (CD) of various types are determined to be the leading causes of disability and morbidity across the world. Despite the fact that such diseases are chronic, accurate and fast clinical decision-making is important. However, availability of alternative technologies, may impede market growth over the forecast period of 2021-2027.
North America is found dominating the lab-on-a-chip and microarrays (biochip) market during the forecasted period Due to the presence of a high-quality healthcare system, the United States lab-on-a-chip and microarrays (biochip) market has a substantial market share in North America. With the escalating pandemic scenario, there is a significant need for COVID-19 rapid testing kits on the market, which is likely to complement the market's expansion in the United States. In resource-constrained situations, microfluidic technology is frequently used in the field of point-of-care (POC) diagnostics for diverse applications such as molecular diagnostics, infectious diseases, and chronic diseases.
Major market player included in this report are:
Danaher Corporation (Cepheid)
Abbott Laboratories
Thermo Fisher Scientific
F. Hoffmann-La Roche Ltd
Bio-Rad Laboratories Inc.
Agilent Technologies Inc.
Fluidigm Corporation
QIAGEN N.V.
PerkinElmer Inc.
GE Healthcare
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
Lab-on-a-chip
Microarray
By Products:
Instruments
Reagents and Consumables
Software and Services
By Application:
Clinical Diagnostics
Drug Discovery
Genomics and Proteomics
Other Applications
By End user:
Biotechnology & Pharmaceutical Companies
Hospitals & Diagnostics Centers
Academic & Research Institutes
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027.
Target Audience of the Global Lab-on-a-Chip and Microarrays (Biochip) Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
North America is found dominating the lab-on-a-chip and microarrays (biochip) market during the forecasted period Due to the presence of a high-quality healthcare system, the United States lab-on-a-chip and microarrays (biochip) market has a substantial market share in North America. With the escalating pandemic scenario, there is a significant need for COVID-19 rapid testing kits on the market, which is likely to complement the market's expansion in the United States. In resource-constrained situations, microfluidic technology is frequently used in the field of point-of-care (POC) diagnostics for diverse applications such as molecular diagnostics, infectious diseases, and chronic diseases.
Major market player included in this report are:
Danaher Corporation (Cepheid)
Abbott Laboratories
Thermo Fisher Scientific
F. Hoffmann-La Roche Ltd
Bio-Rad Laboratories Inc.
Agilent Technologies Inc.
Fluidigm Corporation
QIAGEN N.V.
PerkinElmer Inc.
GE Healthcare
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
Lab-on-a-chip
Microarray
By Products:
Instruments
Reagents and Consumables
Software and Services
By Application:
Clinical Diagnostics
Drug Discovery
Genomics and Proteomics
Other Applications
By End user:
Biotechnology & Pharmaceutical Companies
Hospitals & Diagnostics Centers
Academic & Research Institutes
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027.
Target Audience of the Global Lab-on-a-Chip and Microarrays (Biochip) Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Lab-On-A-Chip And Microarrays (Biochip) Market, By Region, 2019-2027 (USD Billion)
1.2.2. Lab-On-A-Chip And Microarrays (Biochip) Market, By type, 2019-2027 (USD Billion)
1.2.3. Lab-On-A-Chip And Microarrays (Biochip) Market, By Products, 2019-2027 (USD Billion)
1.2.4. Lab-On-A-Chip And Microarrays (Biochip) Market, By Application, 2019-2027 (USD Billion)
1.2.5. Lab-On-A-Chip And Microarrays (Biochip) Market, By End User, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Lab-On-A-Chip And Microarrays (Biochip) Market Definition And Scope
2.1. Objective Of The Study
2.2. Market Definition & Scope
2.2.1. Scope Of The Study
2.2.2. Industry Evolution
2.3. Years Considered For The Study
2.4. Currency Conversion Rates
Chapter 3. Global Lab-On-A-Chip And Microarrays (Biochip) Market Dynamics
3.1. Lab-On-A-Chip And Microarrays (Biochip) Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Increasing incidences of chronic diseases
3.1.1.2. Increasing application of proteomics and genomics in cancer research
3.1.2. Market Restraint
3.1.2.1. Availability of alternative technologies
3.1.2.2. Design constraints of lab-on-chip technology
3.1.3. Market Opportunities
3.1.3.1. Rapid increase in demand for point-of-care diagnosis
Chapter 4. Global Lab-On-A-Chip And Microarrays (Biochip) Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power Of Suppliers
4.1.2. Bargaining Power Of Buyers
4.1.3. Threat Of New Entrants
4.1.4. Threat Of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach To Porter’s 5 Force Model (2018-2027)
4.2. Pest Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Lab-On-A-Chip And Microarrays (Biochip) Market, By Type
5.1. Market Snapshot
5.2. Global Lab-On-A-Chip And Microarrays (Biochip) Market By Type, Performance - Potential Analysis
5.3. Global Lab-On-A-Chip And Microarrays (Biochip) Market Estimates & Forecasts By Type 2018-2027 (USD Billion)
5.4. Lab-On-A-Chip And Microarrays (Biochip) Market , Sub Segment Analysis
5.4.1. Lab-on-a-chip
5.4.2. Microarray
Chapter 6. Global Lab-On-A-Chip And Microarrays (Biochip) Market, By Products
6.1. Market Snapshot
6.2. Global Lab-On-A-Chip And Microarrays (Biochip) Market By Products, Performance - Potential Analysis
6.3. Global Lab-On-A-Chip And Microarrays (Biochip) Market Estimates & Forecasts By Products 2018-2027 (USD Billion)
6.4. Lab-On-A-Chip And Microarrays (Biochip) Market , Sub Segment Analysis
6.4.1. Instruments
6.4.2. Reagents and Consumables
6.4.3. Software and Services
Chapter 7. Global Lab-On-A-Chip And Microarrays (Biochip) Market, By Application
7.1. Market Snapshot
7.2. Global Lab-On-A-Chip And Microarrays (Biochip) Market By Application, Performance - Potential Analysis
7.3. Global Lab-On-A-Chip And Microarrays (Biochip) Market Estimates & Forecasts By Application 2018-2027 (USD Billion)
7.4. Lab-On-A-Chip And Microarrays (Biochip) Market , Sub Segment Analysis
7.4.1. Clinical Diagnostics
7.4.2. Drug Discovery
7.4.3. Genomics and Proteomics
7.4.4. Other Applications
Chapter 8. Global Lab-On-A-Chip And Microarrays (Biochip) Market, By End User
8.1. Market Snapshot
8.2. Global Lab-On-A-Chip And Microarrays (Biochip) Market By End User Industry, Performance - Potential Analysis
8.3. Global Lab-On-A-Chip And Microarrays (Biochip) Market Estimates & Forecasts By End User Industry 2018-2027 (USD Billion)
8.4. Lab-On-A-Chip And Microarrays (Biochip) Market , Sub Segment Analysis
8.4.1. Biotechnology & Pharmaceutical Companies
8.4.2. Hospitals & Diagnostics Centers
8.4.3. Academic & Research Institutes
Chapter 9. Global Lab-On-A-Chip And Microarrays (Biochip) Market, Regional Analysis
9.1. Lab-On-A-Chip And Microarrays (Biochip) Market , Regional Market Snapshot
9.2. North America Lab-On-A-Chip And Microarrays (Biochip) Market
9.2.1. U.S. Lab-On-A-Chip And Microarrays (Biochip) Market
9.2.1.1. Type Breakdown Estimates & Forecasts, 2018-2027
9.2.1.2. Products Breakdown Estimates & Forecasts, 2018-2027
9.2.1.3. Application Breakdown Estimates & Forecasts, 2018-2027
9.2.1.4. End User Breakdown Estimates & Forecasts, 2018-2027
9.2.2. Canada Lab-On-A-Chip And Microarrays (Biochip) Market
9.3. Europe Lab-On-A-Chip And Microarrays (Biochip) Market Snapshot
9.3.1. U.K. Lab-On-A-Chip And Microarrays (Biochip) Market
9.3.2. Germany Lab-On-A-Chip And Microarrays (Biochip) Market
9.3.3. France Lab-On-A-Chip And Microarrays (Biochip) Market
9.3.4. Spain Lab-On-A-Chip And Microarrays (Biochip) Market
9.3.5. Italy Lab-On-A-Chip And Microarrays (Biochip) Market
9.3.6. Rest Of Europe Lab-On-A-Chip And Microarrays (Biochip) Market
9.4. Asia-Pacific Lab-On-A-Chip And Microarrays (Biochip) Market Snapshot
9.4.1. China Lab-On-A-Chip And Microarrays (Biochip) Market
9.4.2. India Lab-On-A-Chip And Microarrays (Biochip) Market
9.4.3. Japan Lab-On-A-Chip And Microarrays (Biochip) Market
9.4.4. Australia Lab-On-A-Chip And Microarrays (Biochip) Market
9.4.5. South Korea Lab-On-A-Chip And Microarrays (Biochip) Market
9.4.6. Rest Of Asia Pacific Lab-On-A-Chip And Microarrays (Biochip) Market
9.5. Latin America Lab-On-A-Chip And Microarrays (Biochip) Market Snapshot
9.5.1. Brazil Lab-On-A-Chip And Microarrays (Biochip) Market
9.5.2. Mexico Lab-On-A-Chip And Microarrays (Biochip) Market
9.6. Rest Of The World Lab-On-A-Chip And Microarrays (Biochip) Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Danaher Corporation (Cepheid)
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject To Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Abbott Laboratories
10.2.3. Thermo Fisher Scientific
10.2.4. F. Hoffmann-La Roche Ltd
10.2.5. Bio-Rad Laboratories Inc.
10.2.6. Agilent Technologies Inc.
10.2.7. Fluidigm Corporation
10.2.8. QIAGEN N.V.
10.2.9. PerkinElmer Inc.
10.2.10. GE Healthcare
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Lab-On-A-Chip And Microarrays (Biochip) Market, By Region, 2019-2027 (USD Billion)
1.2.2. Lab-On-A-Chip And Microarrays (Biochip) Market, By type, 2019-2027 (USD Billion)
1.2.3. Lab-On-A-Chip And Microarrays (Biochip) Market, By Products, 2019-2027 (USD Billion)
1.2.4. Lab-On-A-Chip And Microarrays (Biochip) Market, By Application, 2019-2027 (USD Billion)
1.2.5. Lab-On-A-Chip And Microarrays (Biochip) Market, By End User, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Lab-On-A-Chip And Microarrays (Biochip) Market Definition And Scope
2.1. Objective Of The Study
2.2. Market Definition & Scope
2.2.1. Scope Of The Study
2.2.2. Industry Evolution
2.3. Years Considered For The Study
2.4. Currency Conversion Rates
Chapter 3. Global Lab-On-A-Chip And Microarrays (Biochip) Market Dynamics
3.1. Lab-On-A-Chip And Microarrays (Biochip) Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Increasing incidences of chronic diseases
3.1.1.2. Increasing application of proteomics and genomics in cancer research
3.1.2. Market Restraint
3.1.2.1. Availability of alternative technologies
3.1.2.2. Design constraints of lab-on-chip technology
3.1.3. Market Opportunities
3.1.3.1. Rapid increase in demand for point-of-care diagnosis
Chapter 4. Global Lab-On-A-Chip And Microarrays (Biochip) Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power Of Suppliers
4.1.2. Bargaining Power Of Buyers
4.1.3. Threat Of New Entrants
4.1.4. Threat Of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach To Porter’s 5 Force Model (2018-2027)
4.2. Pest Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Lab-On-A-Chip And Microarrays (Biochip) Market, By Type
5.1. Market Snapshot
5.2. Global Lab-On-A-Chip And Microarrays (Biochip) Market By Type, Performance - Potential Analysis
5.3. Global Lab-On-A-Chip And Microarrays (Biochip) Market Estimates & Forecasts By Type 2018-2027 (USD Billion)
5.4. Lab-On-A-Chip And Microarrays (Biochip) Market , Sub Segment Analysis
5.4.1. Lab-on-a-chip
5.4.2. Microarray
Chapter 6. Global Lab-On-A-Chip And Microarrays (Biochip) Market, By Products
6.1. Market Snapshot
6.2. Global Lab-On-A-Chip And Microarrays (Biochip) Market By Products, Performance - Potential Analysis
6.3. Global Lab-On-A-Chip And Microarrays (Biochip) Market Estimates & Forecasts By Products 2018-2027 (USD Billion)
6.4. Lab-On-A-Chip And Microarrays (Biochip) Market , Sub Segment Analysis
6.4.1. Instruments
6.4.2. Reagents and Consumables
6.4.3. Software and Services
Chapter 7. Global Lab-On-A-Chip And Microarrays (Biochip) Market, By Application
7.1. Market Snapshot
7.2. Global Lab-On-A-Chip And Microarrays (Biochip) Market By Application, Performance - Potential Analysis
7.3. Global Lab-On-A-Chip And Microarrays (Biochip) Market Estimates & Forecasts By Application 2018-2027 (USD Billion)
7.4. Lab-On-A-Chip And Microarrays (Biochip) Market , Sub Segment Analysis
7.4.1. Clinical Diagnostics
7.4.2. Drug Discovery
7.4.3. Genomics and Proteomics
7.4.4. Other Applications
Chapter 8. Global Lab-On-A-Chip And Microarrays (Biochip) Market, By End User
8.1. Market Snapshot
8.2. Global Lab-On-A-Chip And Microarrays (Biochip) Market By End User Industry, Performance - Potential Analysis
8.3. Global Lab-On-A-Chip And Microarrays (Biochip) Market Estimates & Forecasts By End User Industry 2018-2027 (USD Billion)
8.4. Lab-On-A-Chip And Microarrays (Biochip) Market , Sub Segment Analysis
8.4.1. Biotechnology & Pharmaceutical Companies
8.4.2. Hospitals & Diagnostics Centers
8.4.3. Academic & Research Institutes
Chapter 9. Global Lab-On-A-Chip And Microarrays (Biochip) Market, Regional Analysis
9.1. Lab-On-A-Chip And Microarrays (Biochip) Market , Regional Market Snapshot
9.2. North America Lab-On-A-Chip And Microarrays (Biochip) Market
9.2.1. U.S. Lab-On-A-Chip And Microarrays (Biochip) Market
9.2.1.1. Type Breakdown Estimates & Forecasts, 2018-2027
9.2.1.2. Products Breakdown Estimates & Forecasts, 2018-2027
9.2.1.3. Application Breakdown Estimates & Forecasts, 2018-2027
9.2.1.4. End User Breakdown Estimates & Forecasts, 2018-2027
9.2.2. Canada Lab-On-A-Chip And Microarrays (Biochip) Market
9.3. Europe Lab-On-A-Chip And Microarrays (Biochip) Market Snapshot
9.3.1. U.K. Lab-On-A-Chip And Microarrays (Biochip) Market
9.3.2. Germany Lab-On-A-Chip And Microarrays (Biochip) Market
9.3.3. France Lab-On-A-Chip And Microarrays (Biochip) Market
9.3.4. Spain Lab-On-A-Chip And Microarrays (Biochip) Market
9.3.5. Italy Lab-On-A-Chip And Microarrays (Biochip) Market
9.3.6. Rest Of Europe Lab-On-A-Chip And Microarrays (Biochip) Market
9.4. Asia-Pacific Lab-On-A-Chip And Microarrays (Biochip) Market Snapshot
9.4.1. China Lab-On-A-Chip And Microarrays (Biochip) Market
9.4.2. India Lab-On-A-Chip And Microarrays (Biochip) Market
9.4.3. Japan Lab-On-A-Chip And Microarrays (Biochip) Market
9.4.4. Australia Lab-On-A-Chip And Microarrays (Biochip) Market
9.4.5. South Korea Lab-On-A-Chip And Microarrays (Biochip) Market
9.4.6. Rest Of Asia Pacific Lab-On-A-Chip And Microarrays (Biochip) Market
9.5. Latin America Lab-On-A-Chip And Microarrays (Biochip) Market Snapshot
9.5.1. Brazil Lab-On-A-Chip And Microarrays (Biochip) Market
9.5.2. Mexico Lab-On-A-Chip And Microarrays (Biochip) Market
9.6. Rest Of The World Lab-On-A-Chip And Microarrays (Biochip) Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Danaher Corporation (Cepheid)
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject To Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Abbott Laboratories
10.2.3. Thermo Fisher Scientific
10.2.4. F. Hoffmann-La Roche Ltd
10.2.5. Bio-Rad Laboratories Inc.
10.2.6. Agilent Technologies Inc.
10.2.7. Fluidigm Corporation
10.2.8. QIAGEN N.V.
10.2.9. PerkinElmer Inc.
10.2.10. GE Healthcare
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
no record found